VANDERLINDEN Thierry V.
- Country
- France
- Department
- a
Research Overview
- Evaluation of Landiolol Hydrochloride Versus Standard Care in Reducing Mortality in Septic Shock Patients with Hypercontractility: A Randomized Controlled Trial
- Evaluation of Nicotinamide Supplementation in Preventing Major Adverse Kidney Events in Septic Shock: A Multicenter Randomized Controlled Trial
Data & Insights
Has run more than one trial at 8 of 38 partner sites.
Specializations
Critical Care Medicine
The investigator specializes in managing severe conditions in intensive care, with particular emphasis on septic shock and its complications. Their research explores innovative therapeutic approaches for critical care patients.
- Septic Shock Management
- Intensive Care Medicine
- Critical Care Therapeutics
Their work includes evaluating various therapeutic interventions for improving patient outcomes in intensive care settings.
Cardiovascular Critical Care
Focused on cardiac complications during septic conditions, particularly studying hypercontractility and tachycardia in shock patients. The investigator explores cardiovascular interventions in critical care scenarios.
- Cardiac Function in Sepsis
- Heart Rate Management
- Hemodynamic Monitoring
Their research addresses cardiovascular complications in critically ill patients.
Therapeutic Innovations
Investigating novel therapeutic approaches including vitamin B3 supplementation and specialized cardiac medications for critical care patients. The research focuses on preventing organ dysfunction during severe illness.
- Nutritional Interventions
- Renal Protection Strategies
- Mortality Prevention
Their investigations aim to improve survival rates through innovative therapeutic strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.